Conference · Boston, Massachusetts
Bispecific Antibodies 2012
Health
Key numbers
- Editions on record
- 4first in 2011
About Bispecific Antibodies
Bispecific and multiclonal antibodies are one of the most promising and exciting areas of protein engineering. Since 2009, there have been deals made in excess of $6.5 billion on bispecifics, and the range of therapeutic uses for bispecific antibodies are being expanding beyond oncology to diseases of the immune system, heart and CNS. This meeting will explore the remaining challenges and profile creative problem solving that has been used to make successful bispecific formats. The latest approaches for dual-targeting as well as targeting two different epitopes of the same receptor will be explored for improving efficacy.
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2014 | 8–9 May 2014 | Seaport World Trade Center Boston Boston, Massachusetts | — | — |
| 2013 | 2–3 May 2013 | Seaport World Trade Center Boston Boston, Massachusetts | — | — |
| 2012 | 2–3 May 2012 | The Boston Park Plaza Boston, Massachusetts | — | — |
| 2011 | 11–12 May 2011 | Sheraton Boston Hotel & Towers Boston, Massachusetts | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.